LR565

Interim study to examine whether adding antidepressant, antipsychotic, and anticonvulsant drugs to the medicaid preferred drug list would be of benefit to Nebraska medicaid or Nebraska medicaid clients

Back to Bill Detail
Print Friendly
LR565 Actions
Date Description Journal
Apr 02, 2014 Referred to Health and Human Services Committee 1356
Mar 26, 2014 Referred to Executive Board 1147
Mar 26, 2014 Date of introduction 1147